Regenerative Medicine Market 2019
Language:
Japanese
Product Code No:
C61110600
Issued In:
2019/06
#of Pages:
160
Publication Cycle:
Format:
PDF
Geographic Coverage:
Japan
,
United States
Industry:
Coverage: (Product/service)
Regenerative Medicine
Research Target:
Pharmaceutical R&D Institutions and Companies
Research Content:
I Market Overview
- Regenerative Medicine Market Overview
- Newsworthy Trends of Regenerative Medicine Market
- Regenerative medicine products launched
- Induced pluripotent stem cells or iPS cells
- MUSE cells
- SAKIGAKE Designation System: promoting R&D in Japan aiming at early practical application for innovative pharmaceutical products, medical devices, and regenerative medicines.
- Enhancement of regulations on regenerative medicine
- Actions to build the supply chains for regenerative medicine products
II Trends of R&D
- Trends of R&D
- Trends of Studies on Induced pluripotent stem cells or iPS cells
III Laws and Policies
- Regulations regarding Regenerative Medicine
- Trends of Policies on R&D for Medicines
- Health and Medical strategies
- Science, Technology and Innovation by Cabinet Office
- AMED attempts
- Regenerative Medicine Project
- Achievements and Future Attempts
IV Market Trends
- Alignment of Studies and Business of Regenerative Medicine
- Market Size
V Overseas Trends
- Product Trends
- Products Launched
- Trends of R&D
- Trends of Policies (US, Europe)
- Trends of Regulations (US, Europe)
VI Company Profiles
- Japan Tissue Engineering Co., Ltd.
- StemCell Institute.
- TWOCELLS COMPANY, LIMITED
- tella, Inc
- FUJIFILM Wako Pure Chemical Corporation
- VERITAS Corporation
- MEDINET Co., Ltd.
- ReproCELL Incorporated
Brief Company Profiles
27 enterprises